Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Systemic Lupus Erythematosus, Sjögren Syndrome, and Mixed Connective Tissue Disease in Children and Adolescents.

Tarvin SE, O'Neil KM.

Pediatr Clin North Am. 2018 Aug;65(4):711-737. doi: 10.1016/j.pcl.2018.04.001. Review.

PMID:
30031495
2.

Mycophenolic acid induces senescence of vascular precursor cells.

Go E, Tarnawsky SP, Shelley WC, Banno K, Lin Y, Gil CH, Blue EK, Haneline LS, O'Neil KM, Yoder MC.

PLoS One. 2018 Mar 14;13(3):e0193749. doi: 10.1371/journal.pone.0193749. eCollection 2018.

3.

Clinical practice variation and need for pediatric-specific treatment guidelines among rheumatologists caring for children with ANCA-associated vasculitis: an international clinician survey.

Westwell-Roper C, Lubieniecka JM, Brown KL, Morishita KA, Mammen C, Wagner-Weiner L, Yen E, Li SC, O'Neil KM, Lapidus SK, Brogan P, Cimaz R, Cabral DA; for ARChiVe Investigators Network within the PedVas initiative.

Pediatr Rheumatol Online J. 2017 Aug 7;15(1):61. doi: 10.1186/s12969-017-0191-z.

4.

Malignancy in Pediatric-onset Systemic Lupus Erythematosus.

Bernatsky S, Clarke AE, Zahedi Niaki O, Labrecque J, Schanberg LE, Silverman ED, Hayward K, Imundo L, Brunner HI, Haines KA, Cron RQ, Oen K, Wagner-Weiner L, Rosenberg AM, O'Neil KM, Duffy CM, von Scheven E, Joseph L, Lee JL, Ramsey-Goldman R.

J Rheumatol. 2017 Oct;44(10):1484-1486. doi: 10.3899/jrheum.170179. Epub 2017 Aug 1.

PMID:
28765255
5.

The catastrophic antiphospholipid syndrome in children.

Go EJL, O'Neil KM.

Curr Opin Rheumatol. 2017 Sep;29(5):516-522. doi: 10.1097/BOR.0000000000000426. Review.

PMID:
28632503
6.

Transcriptional profiles of JIA patient blood with subsequent poor response to methotrexate.

Moncrieffe H, Bennett MF, Tsoras M, Luyrink LK, Johnson AL, Xu H, Dare J, Becker ML, Prahalad S, Rosenkranz M, O'Neil KM, Nigrovic PA, Griffin TA, Lovell DJ, Grom AA, Medvedovic M, Thompson SD.

Rheumatology (Oxford). 2017 Sep 1;56(9):1542-1551. doi: 10.1093/rheumatology/kex206.

PMID:
28582527
7.

Malignancy incidence in 5294 patients with juvenile arthritis.

Zahedi Niaki O, Clarke AE, Ramsey-Goldman R, Yeung R, Hayward K, Oen K, Duffy CM, Rosenberg A, O'Neil KM, von Scheven E, Schanberg L, Labrecque J, Tse SM, Hasija R, Lee JL, Bernatsky S.

RMD Open. 2016 May 2;2(1):e000212. doi: 10.1136/rmdopen-2015-000212. eCollection 2016.

8.

Comparing Presenting Clinical Features in 48 Children With Microscopic Polyangiitis to 183 Children Who Have Granulomatosis With Polyangiitis (Wegener's): An ARChiVe Cohort Study.

Cabral DA, Canter DL, Muscal E, Nanda K, Wahezi DM, Spalding SJ, Twilt M, Benseler SM, Campillo S, Charuvanij S, Dancey P, Eberhard BA, Elder ME, Hersh A, Higgins GC, Huber AM, Khubchandani R, Kim S, Klein-Gitelman M, Kostik MM, Lawson EF, Lee T, Lubieniecka JM, McCurdy D, Moorthy LN, Morishita KA, Nielsen SM, O'Neil KM, Reiff A, Ristic G, Robinson AB, Sarmiento A, Shenoi S, Toth MB, Van Mater HA, Wagner-Weiner L, Weiss JE, White AJ, Yeung RS; ARChiVe Investigators Network within the PedVas Initiative.

Arthritis Rheumatol. 2016 Oct;68(10):2514-26. doi: 10.1002/art.39729.

9.

Development of a Novel Renal Activity Index of Lupus Nephritis in Children and Young Adults.

Brunner HI, Bennett MR, Abulaban K, Klein-Gitelman MS, O'Neil KM, Tucker L, Ardoin SP, Rouster-Stevens KA, Onel KB, Singer NG, Anne Eberhard B, Jung LK, Imundo L, Wright TB, Witte D, Rovin BH, Ying J, Devarajan P.

Arthritis Care Res (Hoboken). 2016 Jul;68(7):1003-11. doi: 10.1002/acr.22762.

10.

National Institutes of Health Pathways to Prevention Workshop: Advancing the Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Green CR, Cowan P, Elk R, O'Neil KM, Rasmussen AL.

Ann Intern Med. 2015 Jun 16;162(12):860-5. doi: 10.7326/M15-0338.

PMID:
26075757
11.

Effects of obesity on health-related quality of life in juvenile-onset systemic lupus erythematosus.

Mina R, Klein-Gitelman MS, Nelson S, Eberhard BA, Higgins G, Singer NG, Onel K, Tucker L, O'Neil KM, Punaro M, Levy DM, Haines K, Ying J, Brunner HI.

Lupus. 2015 Feb;24(2):191-7. doi: 10.1177/0961203314555537. Epub 2014 Oct 21.

12.

Extension study of participants from the trial of early aggressive therapy in juvenile idiopathic arthritis.

Wallace CA, Ringold S, Bohnsack J, Spalding SJ, Brunner HI, Milojevic D, Schanberg LE, Higgins GC, O'Neil KM, Gottlieb BS, Hsu J, Punaro MG, Kimura Y, Hendrickson A.

J Rheumatol. 2014 Dec;41(12):2459-65. doi: 10.3899/jrheum.140347. Epub 2014 Sep 1.

PMID:
25179849
13.

Clinically inactive disease in a cohort of children with new-onset polyarticular juvenile idiopathic arthritis treated with early aggressive therapy: time to achievement, total duration, and predictors.

Wallace CA, Giannini EH, Spalding SJ, Hashkes PJ, O'Neil KM, Zeft AS, Szer IS, Ringold S, Brunner HI, Schanberg LE, Sundel RP, Milojevic DS, Punaro MG, Chira P, Gottlieb BS, Higgins GC, Ilowite NT, Kimura Y, Johnson A, Huang B, Lovell DJ; Childhood Arthritis and Rheumatology Research Alliance (CARRA).

J Rheumatol. 2014 Jun;41(6):1163-70. doi: 10.3899/jrheum.131503. Epub 2014 May 1.

PMID:
24786928
14.

Cancer risk in childhood-onset systemic lupus.

Bernatsky S, Clarke AE, Labrecque J, von Scheven E, Schanberg LE, Silverman ED, Brunner HI, Haines KA, Cron RQ, O'Neil KM, Oen K, Rosenberg AM, Duffy CM, Joseph L, Lee JL, Kale M, Turnbull EM, Ramsey-Goldman R.

Arthritis Res Ther. 2013;15(6):R198.

15.

Semantic association fMRI impairments represent a potential schizophrenia biomarker.

Jamadar SD, Pearlson GD, O'Neil KM, Assaf M.

Schizophr Res. 2013 Apr;145(1-3):20-6. doi: 10.1016/j.schres.2012.12.029. Epub 2013 Feb 8.

16.

Validation of the systemic lupus erythematosus responder index for use in juvenile-onset systemic lupus erythematosus.

Mina R, Klein-Gitelman MS, Nelson S, Eberhard BA, Higgins G, Singer NG, Onel K, Tucker L, O'Neil KM, Punaro M, Levy DM, Haines K, Martini A, Ruperto N, Lovell D, Brunner HI.

Ann Rheum Dis. 2014 Feb;73(2):401-6. doi: 10.1136/annrheumdis-2012-202376. Epub 2013 Jan 23.

PMID:
23345596
17.

Disease activity assessment in childhood vasculitis: development and preliminary validation of the Paediatric Vasculitis Activity Score (PVAS).

Dolezalova P, Price-Kuehne FE, Özen S, Benseler SM, Cabral DA, Anton J, Brunner J, Cimaz R, O'Neil KM, Wallace CA, Wilkinson N, Eleftheriou D, Demirkaya E, Böhm M, Krol P, Luqmani RA, Brogan PA.

Ann Rheum Dis. 2013 Oct;72(10):1628-33. doi: 10.1136/annrheumdis-2012-202111. Epub 2012 Oct 25.

PMID:
23100606
18.

Impairment in semantic retrieval is associated with symptoms in schizophrenia but not bipolar disorder.

Jamadar S, O'Neil KM, Pearlson GD, Ansari M, Gill A, Jagannathan K, Assaf M.

Biol Psychiatry. 2013 Mar 15;73(6):555-64. doi: 10.1016/j.biopsych.2012.07.027. Epub 2012 Sep 15.

19.

Algorithm development for corticosteroid management in systemic juvenile idiopathic arthritis trial using consensus methodology.

Ilowite NT, Sandborg CI, Feldman BM, Grom A, Schanberg LE, Giannini EH, Wallace CA, Schneider R, Kenney K, Gottlieb B, Hashkes PJ, Imundo L, Kimura Y, Lang B, Miller M, Milojevic D, O'Neil KM, Punaro M, Ruth N, Singer NG, Vehe RK, Verbsky J, Woodward A, Zemel L.

Pediatr Rheumatol Online J. 2012 Aug 29;10(1):31. doi: 10.1186/1546-0096-10-31.

20.

Do adult disease severity subclassifications predict use of cyclophosphamide in children with ANCA-associated vasculitis? An analysis of ARChiVe study treatment decisions.

Morishita K, Guzman J, Chira P, Muscal E, Zeft A, Klein-Gitelman M, Uribe AG, Abramson L, Benseler SM, Eberhard A, Ede K, Hashkes PJ, Hersh AO, Higgins G, Imundo LF, Jung L, Kim S, Kingsbury DJ, Lawson EF, Lee T, Li SC, Lovell DJ, Mason T, McCurdy D, O'Neil KM, Punaro M, Ramsey SE, Reiff A, Rosenkranz M, Schikler KN, Scuccimarri R, Singer NG, Stevens AM, van Mater H, Wahezi DM, White AJ, Cabral DA; ARChiVe Investigators Network.

J Rheumatol. 2012 Oct;39(10):2012-20. doi: 10.3899/jrheum.120299. Epub 2012 Aug 1.

PMID:
22859342
21.

Increased sensitivity of the European medicines agency algorithm for classification of childhood granulomatosis with polyangiitis.

Uribe AG, Huber AM, Kim S, O'Neil KM, Wahezi DM, Abramson L, Baszis K, Benseler SM, Bowyer SL, Campillo S, Chira P, Hersh AO, Higgins GC, Eberhard A, Ede K, Imundo LF, Jung L, Kingsbury DJ, Klein-Gitelman M, Lawson EF, Li SC, Lovell DJ, Mason T, McCurdy D, Muscal E, Nassi L, Rabinovich E, Reiff A, Rosenkranz M, Schikler KN, Singer NG, Spalding S, Stevens AM, Cabral DA; ARegistry for Children with Vasculitis e-entry (ARChiVe) Network.

J Rheumatol. 2012 Aug;39(8):1687-97. Epub 2012 May 15.

PMID:
22589257
22.

Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma.

Li SC, Torok KS, Pope E, Dedeoglu F, Hong S, Jacobe HT, Rabinovich CE, Laxer RM, Higgins GC, Ferguson PJ, Lasky A, Baszis K, Becker M, Campillo S, Cartwright V, Cidon M, Inman CJ, Jerath R, O'Neil KM, Vora S, Zeft A, Wallace CA, Ilowite NT, Fuhlbrigge RC; Childhood Arthritis and Rheumatology Research Alliance (CARRA) Localized Scleroderma Workgroup.

Arthritis Care Res (Hoboken). 2012 Aug;64(8):1175-85. doi: 10.1002/acr.21687.

23.

Assessing the performance of the Birmingham Vasculitis Activity Score at diagnosis for children with antineutrophil cytoplasmic antibody-associated vasculitis in A Registry for Childhood Vasculitis (ARChiVe).

Morishita K, Li SC, Muscal E, Spalding S, Guzman J, Uribe A, Abramson L, Baszis K, Benseler S, Bowyer S, Campillo S, Chira P, Hersh AO, Higgins G, Eberhard A, Ede K, Imundo L, Jung L, Kim S, Kingsbury DJ, Klein-Gitelman M, Lawson EF, Lovell DJ, Mason T, McCurdy D, Nanda K, Nassi L, O'Neil KM, Rabinovich E, Ramsey SE, Reiff A, Rosenkranz M, Schikler K, Stevens A, Wahezi D, Cabral DA; ARChiVe Investigators Network.

J Rheumatol. 2012 May;39(5):1088-94. doi: 10.3899/jrheum.111030. Epub 2012 Feb 15.

PMID:
22337238
24.

Inactive disease and remission in childhood-onset systemic lupus erythematosus.

Mina R, Klein-Gitelman MS, Ravelli A, Beresford MW, Avcin T, Espada G, Eberhard BA, Schanberg LE, O'Neil KM, Silva CA, Higgins GC, Onel K, Singer NG, von Scheven E, Imundo LF, Nelson S, Giannini EH, Brunner HI.

Arthritis Care Res (Hoboken). 2012 May;64(5):683-93. doi: 10.1002/acr.21612.

25.

Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis.

Wallace CA, Giannini EH, Spalding SJ, Hashkes PJ, O'Neil KM, Zeft AS, Szer IS, Ringold S, Brunner HI, Schanberg LE, Sundel RP, Milojevic D, Punaro MG, Chira P, Gottlieb BS, Higgins GC, Ilowite NT, Kimura Y, Hamilton S, Johnson A, Huang B, Lovell DJ; Childhood Arthritis and Rheumatology Research Alliance.

Arthritis Rheum. 2012 Jun;64(6):2012-21. doi: 10.1002/art.34343. Epub 2011 Dec 19.

26.

Partial response to anakinra in life-threatening Henoch-Schönlein purpura: case report.

Boyer EM, Turman M, O'Neil KM.

Pediatr Rheumatol Online J. 2011 Aug 11;9(1):21. doi: 10.1186/1546-0096-9-21.

27.

Estimates of the seroprevalence of production-limiting diseases in wild pigs.

Baker SR, O'Neil KM, Gramer MR, Dee SA.

Vet Rec. 2011 May 28;168(21):564. doi: 10.1136/vr.d1020. Epub 2011 May 24. No abstract available.

PMID:
21610003
28.

EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I: Overall methodology and clinical characterisation.

Ruperto N, Ozen S, Pistorio A, Dolezalova P, Brogan P, Cabral DA, Cuttica R, Khubchandani R, Lovell DJ, O'Neil KM, Quartier P, Ravelli A, Iusan SM, Filocamo G, Magalhães CS, Unsal E, Oliveira S, Bracaglia C, Bagga A, Stanevicha V, Manzoni SM, Pratsidou P, Lepore L, Espada G, Kone-Paut I, Zulian F, Barone P, Bircan Z, Maldonado Mdel R, Russo R, Vilca I, Tullus K, Cimaz R, Horneff G, Anton J, Garay S, Nielsen S, Barbano G, Martini A; Paediatric Rheumatology International Trials Organisation (PRINTO).

Ann Rheum Dis. 2010 May;69(5):790-7. doi: 10.1136/ard.2009.116624. Epub 2010 Apr 13. Erratum in: Ann Rheum Dis. 2011 Feb;70(2):397. Paut, Isabelle Kone [corrected to Kone-Paut, Isabella].

PMID:
20388738
29.

Glucocorticoid-responsive hypertension in Henoch-Schonlein purpura.

O'Neil KM, Varma C, Farooq O, Memon A.

Clin Pediatr (Phila). 2010 Jul;49(7):702-6. doi: 10.1177/0009922809359420. Epub 2010 Feb 17. No abstract available.

PMID:
20164069
30.

Treatment of pediatric localized scleroderma: results of a survey of North American pediatric rheumatologists.

Li SC, Feldman BM, Higgins GC, Haines KA, Punaro MG, O'Neil KM.

J Rheumatol. 2010 Jan;37(1):175-81. doi: 10.3899/jrheum.090708. Epub 2009 Nov 16.

PMID:
19918041
31.

Classification, presentation, and initial treatment of Wegener's granulomatosis in childhood.

Cabral DA, Uribe AG, Benseler S, O'Neil KM, Hashkes PJ, Higgins G, Zeft AS, Lovell DJ, Kingsbury DJ, Stevens A, McCurdy D, Chira P, Abramson L, Arkachaisri T, Campillo S, Eberhard A, Hersh AO, Huber AM, Kim S, Klein-Gitelman M, Levy DM, Li SC, Mason T, Dewitt EM, Muscal E, Nassi L, Reiff A, Schikler K, Singer NG, Wahezi D, Woodward A; ARChiVe (A Registry for Childhood Vasculitis: e-entry) Investigators Network.

Arthritis Rheum. 2009 Nov;60(11):3413-24. doi: 10.1002/art.24876.

32.

The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress toward development of localized scleroderma outcome measures.

Arkachaisri T, Vilaiyuk S, Li S, O'Neil KM, Pope E, Higgins GC, Punaro M, Rabinovich EC, Rosenkranz M, Kietz DA, Rosen P, Spalding SJ, Hennon TR, Torok KS, Cassidy E, Medsger TA Jr; Localized Scleroderma Clinical and Ultrasound Study Group.

J Rheumatol. 2009 Dec;36(12):2819-29. doi: 10.3899/jrheum.081284. Epub 2009 Oct 15.

33.

Progress in pediatric vasculitis.

O'Neil KM.

Curr Opin Rheumatol. 2009 Sep;21(5):538-46. doi: 10.1097/BOR.0b013e32832f13f1. Review.

PMID:
19568171
34.

Gene expression profiling in neutrophils from children with polyarticular juvenile idiopathic arthritis.

Jarvis JN, Jiang K, Frank MB, Knowlton N, Aggarwal A, Wallace CA, McKee R, Chaser B, Tung C, Smith LB, McGhee JL, Chen Y, Osban J, O'Neil KM, Centola M.

Arthritis Rheum. 2009 May;60(5):1488-95. doi: 10.1002/art.24450.

35.

Continuing medical education effect on physician knowledge application and psychomotor skills: effectiveness of continuing medical education: American College of Chest Physicians Evidence-Based Educational Guidelines.

O'Neil KM, Addrizzo-Harris DJ; American College of Chest Physicians Health and Science Policy Committee.

Chest. 2009 Mar;135(3 Suppl):37S-41S. doi: 10.1378/chest.08-2516. Review.

PMID:
19265074
36.

Initial validation of a novel protein biomarker panel for active pediatric lupus nephritis.

Suzuki M, Wiers K, Brooks EB, Greis KD, Haines K, Klein-Gitelman MS, Olson J, Onel K, O'Neil KM, Silverman ED, Tucker L, Ying J, Devarajan P, Brunner HI.

Pediatr Res. 2009 May;65(5):530-6. doi: 10.1203/PDR.0b013e31819e4305.

37.

Outcome of aspirin treatment of antiphospholipid antibody-positive patients.

O'Neil KM.

Curr Rheumatol Rep. 2009 Feb;11(1):1-2. No abstract available.

PMID:
19171105
38.

Primary thrombosis prevention in aPL-positive patients.

O'Neil KM.

Curr Rheumatol Rep. 2008 Jan;10(1):59-61. No abstract available.

PMID:
18457613
39.

Should aspirin be used as a preventive therapy for thrombosis in patients with antiphospholipid antibodies?

O'Neil KM.

Nat Clin Pract Rheumatol. 2008 Jan;4(1):14-5. Epub 2007 Nov 27. No abstract available.

PMID:
18043598
40.

Familial lupus and antiphospholipid syndrome.

Sestak A, O'Neil KM.

Lupus. 2007;16(8):556-63. Review.

PMID:
17711888
41.

Human CD4(+) memory T-lymphocyte responses to SARS coronavirus infection.

Libraty DH, O'Neil KM, Baker LM, Acosta LP, Olveda RM.

Virology. 2007 Nov 25;368(2):317-21. Epub 2007 Aug 13.

42.

Role of complement in antiphospholipid antibody-mediated thrombosis.

O'Neil KM.

Curr Rheumatol Rep. 2007 Jun;9(3):205-11. Review.

PMID:
17531173
43.

High-intensity warfarin versus conventional antithrombotic therapy to prevent thrombosis in antiphospholipid syndrome.

O'Neil KM.

Curr Rheumatol Rep. 2007 Jun;9(3):188-9. No abstract available.

PMID:
17531170
44.

Low molecular weight heparin to prevent antiphospholipid syndrome morbidity in pregnancy.

O'Neil KM.

Curr Rheumatol Rep. 2007 Jun;9(3):187-8. No abstract available.

PMID:
17531169
45.

Secondary prevention: warfarin therapy in antiphospholipid syndrome.

O'Neil KM.

Curr Rheumatol Rep. 2007 Jun;9(3):187. No abstract available.

PMID:
17531168
46.

Winners of the 2005 American College of Rheumatology Annual Slide Competition.

Wolpaw TM, Baer AN, Gall EP, Miller ML, Noss EH, O'Neil KM; American College of Rheumatology Audiovisual Aids Subcommittee.

Arthritis Rheum. 2006 Mar;54(3):690-1. No abstract available.

47.

The pulmonary status of patients with limited-stage small cell lung cancer 15 years after treatment with chemotherapy and chest irradiation.

Myers JN, O'neil KM, Walsh TE, Hoffmeister KJ, Venzon DJ, Johnson BE.

Chest. 2005 Nov;128(5):3261-8.

PMID:
16304271
48.

Web-based research: methodological variables' effects on dropout and sample characteristics.

O'Neil KM, Penrod SD, Bornstein BH.

Behav Res Methods Instrum Comput. 2003 May;35(2):217-26.

PMID:
12834076
49.

The changing landscape of HIV-related lung disease in the era of highly active antiretroviral therapy.

O'Neil KM.

Chest. 2002 Sep;122(3):768-71. No abstract available.

PMID:
12226010
50.

Supplemental Content

Loading ...
Support Center